Yvan Guindon is a Research Professor at the Institut de recherches cliniques de Montréal (IRCM) and at the Department of Chemistry, Université de Montréal. He obtained his B.Sc. and Ph.D at the Université de Montréal.
He started at Merck Frosst in 1979 and held different leading positions including Senior Director of Medicinal Chemistry. From 1987 to 2004, he was Vice-President Research at BioMega/Boehringer Ingelheim Research Canada. He moved to Academic in 1994 when he directed the Bio-Organic Chemistry Laboratory, From 1994 to 2004, he was also Chief Executive Members Officer and Scientific Director of the IRCM.
His research interests were centered on the discovery of potential therapeutics for asthma, hypertension, HIV and other viral infections. Recently, his work targets anti-inflammatory pathways and pancreatic cancer in collaboration with Dr. Nemer’s Laboratory (University of Ottawa). His group is aiming to discover cardio-protective agents for patients receiving antineoplastic drugs. He is also recognized for his contribution in free-radical chemistry and the synthesis of natural products and nucleoside analogues.
Dr. Guindon was elected to the Academy of Sciences of the Royal Society of Canada in 1990. He was named to the Order of Canada in 2005. In 2006, he received the Prix Lionel-Boulet, Prix du Québec, for his contributions to the biopharmaceutical sector. He was President from 2007-2009 of the RSC: The Academies of Arts, Humanities and Sciences of Canada (The Royal Society of Canada). In 2012, he received the Alfred-Bader Award, from the Canadian Society for Chemistry, for the excellence of his contributions in Organic Chemistry. He was also received as a Knight of National Order of Québec the same year. He is Fellow of the American Association for the Advancement of Science since 2014.